In the mRNA-CRID-001 trial, researchers are evaluating the safety, effectiveness, and immune response of investigational mRNA vaccines and how they work in the body. Research dedicated to understanding immune system responses can provide valuable insights during the development of new medicines and treatments, including mRNA vaccines.
The purpose of this clinical trial is to analyze the human body’s response to several mRNA vaccines and an approved flu vaccine. Of the four different mRNA vaccines tested in this trial, three are investigational (still being researched), and one has been approved for the prevention of COVID-19.
Since people may respond differently to medical treatments and vaccines, it is important to identify similarities, differences, and patterns between how mRNA vaccines work in the body to protect against viruses. You can help advance important research to better understand how the immune system responds to mRNA vaccines.
Participation in the CRID Trial is approximately 19 months. You will be compensated for your time. Eligible participants must be:
• 18-75 years of age
• Be in generally good health